BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33353270)

  • 21. Pretreatment Tumor Thickness as a Predictor of Pathologic Complete Response to Neoadjuvant Chemoradiation Therapy for Stage II/III Rectal Adenocarcinoma.
    Xu B; Chen Y; Guo Y; Zhou D; Yue Z; Duan Q; Yang Y; Guan G; Chi P; Lin C
    Am J Clin Oncol; 2018 Jun; 41(6):601-606. PubMed ID: 27672742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of preservation of left colic artery on postoperative anastomotic leakage of patients with rectal cancer after neoadjuvant therapy].
    Teng WH; Wei C; Liu WJ; Liu S; Chen S; Zang WD
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):566-572. PubMed ID: 31238636
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluating predictive factors for determining the presence of lateral pelvic node metastasis in rectal cancer patients following neoadjuvant chemoradiotherapy.
    Wang P; Zhou S; Zhou H; Liang J; Zhou Z
    Colorectal Dis; 2019 Jul; 21(7):791-796. PubMed ID: 30801862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy.
    Smith FM; Wiland H; Mace A; Pai RK; Kalady MF
    Dis Colon Rectum; 2014 Mar; 57(3):311-5. PubMed ID: 24509452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Predictive value of preoperative imaging and postoperative pathology on clinical complete response after neoadjuvant chemoradiation for locally advanced rectal cancer].
    Xiao Y; Xue H; Zhong G; Zhou W; Xu L; Du X; Zhang G; Wu B; Lin G; Qiu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 May; 18(5):474-7. PubMed ID: 26013867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer.
    Peng J; Lin J; Qiu M; Wu X; Lu Z; Chen G; Li L; Ding P; Gao Y; Zeng Z; Zhang H; Wan D; Pan Z
    Clinics (Sao Paulo); 2016 Aug; 71(8):449-54. PubMed ID: 27626475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
    Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
    [No Abstract]   [Full Text] [Related]  

  • 28. Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer.
    Shiraishi T; Sasaki T; Ikeda K; Tsukada Y; Nishizawa Y; Ito M
    BMC Cancer; 2019 Dec; 19(1):1222. PubMed ID: 31842797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
    Zhang Q; Liang J; Chen J; Mei S; Wang Z
    Asian Pac J Cancer Prev; 2021 May; 22(5):1607-1611. PubMed ID: 34048192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
    Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
    Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS
    Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An initial exploration of the application of transanal endoscopic microsurgery in rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy].
    Xue XQ; Zhou JL; Lin GL; Bai XS; Xiao Y; Wu B; Qiu HZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):560-565. PubMed ID: 31238635
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathologic complete response implies a fewer number of lymph nodes in specimen of rectal cancer patients treated by neoadjuvant therapy and total mesorectal excision.
    Bustamante-Lopez LA; Nahas CSR; Nahas SC; Marques CFS; Pinto RA; Cotti GC; Imperiale AR; de Mello ES; Ribeiro U; Cecconello I
    Int J Surg; 2018 Aug; 56():283-287. PubMed ID: 29981939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer.
    Ren DL; Li J; Yu HC; Peng SY; Lin WD; Wang XL; Ghoorun RA; Luo YX
    World J Gastroenterol; 2019 Jan; 25(1):118-137. PubMed ID: 30643363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy.
    Petrucciani N; Carra MC; Martínez-Pérez A; Vitali GC; Landi F; Genova P; Memeo R; Brunetti F; Espin E; Ris F; De'angelis N;
    Anticancer Res; 2019 Apr; 39(4):2113-2120. PubMed ID: 30952757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer.
    Maretto I; Pomerri F; Pucciarelli S; Mescoli C; Belluco E; Burzi S; Rugge M; Muzzio PC; Nitti D
    Ann Surg Oncol; 2007 Feb; 14(2):455-61. PubMed ID: 17139456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopathological characteristics and prognostic analysis of patients with pathological complete response and near complete response after neoadjuvant treatment of rectal cancer].
    Li DD; Zhang QQ; Wu YL; Shen SH; Fang H; Zhu YL; Zhang HZ
    Zhonghua Yi Xue Za Zhi; 2021 May; 101(18):1357-1362. PubMed ID: 34015870
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study.
    Dietz DW; Dehdashti F; Grigsby PW; Malyapa RS; Myerson RJ; Picus J; Ritter J; Lewis JS; Welch MJ; Siegel BA
    Dis Colon Rectum; 2008 Nov; 51(11):1641-8. PubMed ID: 18682881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of Pathological Complete Response Using Endoscopic Findings and Outcomes of Patients Who Underwent Watchful Waiting After Chemoradiotherapy for Rectal Cancer.
    Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Morikawa T; Fukayama M; Watanabe T
    Dis Colon Rectum; 2017 Apr; 60(4):368-375. PubMed ID: 28267003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.